| Identification | Back Directory | [Name]
clorobiocin | [CAS]
39868-96-7 | [Synonyms]
18631RP
RP-18631
clorobiocin
Chlorobiocin
Antibiotic RP-18631
N-[7-[[3-O-(5-Methyl-1H-pyrrol-2-ylcarbonyl)-4-O,5-C-dimethyl-6-deoxy-α-L-lyxo-hexopyranosyl]oxy]-8-chloro-4-hydroxy-2-oxo-2H-1-benzopyran-3-yl]-3-(3-methyl-2-butenyl)-4-hydroxybenzamide
Benzamide, N-[8-chloro-7-[[6-deoxy-5-C-methyl-4-O-methyl-3-O-[(5-methyl-1H-pyrrol-2-yl)carbonyl]-α-L-lyxo-hexopyranosyl]oxy]-4-hydroxy-2-oxo-2H-1-benzopyran-3-yl]-4-hydroxy-3-(3-methyl-2-buten-1-yl)- | [Molecular Formula]
C35H37ClN2O11 | [MDL Number]
MFCD01939925 | [MOL File]
39868-96-7.mol | [Molecular Weight]
697.133 |
| Hazard Information | Back Directory | [Uses]
Clorobiocin is a MlaC protein inhibitor that could bind to the MlaC protein. Clorobiocin has antibacterial effects[1]. | [References]
[1] Yu-Ming M Huang, et al. Docking simulation and antibiotic discovery targeting the MlaC protein in Gram-negative bacteria. Chem Biol Drug Des. 2019 Apr;93(4):647-652. DOI:10.1111/cbdd.13462 |
|
| Company Name: |
BOC Sciences
|
| Tel: |
16314854226 |
| Website: |
www.bocsci.com |
|